STARS Webinar - Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials-Traduction audio en français

Video Transcription

Video Summary

The webinar titled "Finding the Right Dose: Using Patient Data in Early Phase Clinical Trials" focused on the importance of patient data and perspectives in determining the appropriate dosage for drugs, particularly in early phase clinical trials. The webinar involved several presenters, including Dr. Belinda King-Kalimanis, Director of Patient Advocacy Research at Longevity, Anne Loeser, a lung cancer patient and founder of the Patient-Centered Dosing Initiative (PCDI), Lee Jones, a colon cancer survivor and cancer research advocate, and Janice Cowden, a member of PCDI and the Dosage Initiative. The webinar highlighted common misunderstandings about patient reported data, the potential impact of patient experiences on dose optimization, and the role of patient research advocates in discussions about dosing. Additionally, the presenters discussed the FDA's Project Optimus, which aims to reform dose optimization and selection, and the importance of involving patients in clinical trials to improve outcomes and quality of life. The presenters emphasized the need for personalized medicine and individualized dosing strategies to better serve patients' unique needs and preferences. Overall, the webinar provided valuable insights into the role of patient data in drug development and the importance of incorporating patient perspectives in dosing decisions.

Asset Subtitle

(French Audio Translation)

Meta Tag

Concept Maximum Tolerated Dose

Concept Dose Optimization

Concept Longitudinal Patient-Reported Outcome

Concept Project Optimus

Concept Patient-Centered Dosing Initiative

Keywords

Finding the Right Dose

Patient Data

Early Phase Clinical Trials

Dosage Optimization

Patient Perspectives

Patient Advocacy Research

Patient-Centered Dosing Initiative

FDA Project Optimus

Personalized Medicine

Dosing Decisions

Maximum Tolerated Dose

Dose Optimization

Longitudinal Patient-Reported Outcome

Project Optimus

Patient-Centered Dosing Initiative